Ekonomi Bölümü Koleksiyonu

Permanent URI for this collectionhttps://hdl.handle.net/20.500.11779/1936

Browse

Browsing Ekonomi Bölümü Koleksiyonu by Department "İİSBF, Psikoloji Bölümü"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Thumbnail Image
    Article
    Citation - WoS: 6
    Citation - Scopus: 8
    Gendering Resistance: Multiple Faces of the Kurdish Women's Struggle
    (Wiley, 2019) Göksel, Nisa
    The article explores the Kurdish women's movement in Turkey by bridging two forms of resistance: those of guerrilla women fighters and of activist women. Based on my extensive ethnographic and archival research, I ask how women under conditions of war engage in different modes of resistance. In what ways does the "heroic resistance" of guerrilla women resonate with and/or contradict the everyday, "ordinary" struggles of activist women? The potent image of the Kurdish guerrilla woman that emerged in the early 1990s is constitutive of many other modes of political subjectivities, even among women who do not or cannot become guerrillas. One of those subjectivities is that of the activist woman. My analysis suggests that women's activism opens up a middle ground of action between "heroic" and "ordinary" resistance by reconciling revolutionary politics with everyday activism around gender-based violence, democracy, and human rights. Although both revolutionary movement participants and scholars of revolutionary resistance often contrast the "ordinary" with the realm of armed resistance, this article challenges this dichotomy. I take the two realms of resistance-the ordinary and the heroic-as the core constituents of revolutionary resistance, and I reconsider the gendered interplay between them.
  • Thumbnail Image
    Article
    Citation - WoS: 59
    Citation - Scopus: 60
    Risk of Stroke/Systemic Embolism, Major Bleeding and Associated Costs in Non-Valvular Atrial Fibrillation Patients Who Initiated Apixaban, Dabigatran or Rivaroxaban Compared With Warfarin in the United States Medicare Population
    (2017) Amin, Alpesh; Lien Vo; Trocio, Jeffrey; Keshishian, A; Liu, Xianchen; Mardekian, Jack; Zhang, Qisu; Rosenblatt, Lisa; Dina, Oluwaseyi; Başer, Onur; Le, Hannah
    Objective: To compare the risk and cost of stroke/systemic embolism (SE) and major bleeding between each direct oral anticoagulant (DOAC) and warfarin among non-valvular atrial fibrillation (NVAF) patients. Methods: Patients (65 years) initiating warfarin or DOACs (apixaban, rivaroxaban, and dabigatran) were selected from the Medicare database from 1 January 2013 to 31 December 2014. Patients initiating each DOAC were matched 1:1 to warfarin patients using propensity score matching to balance demographics and clinical characteristics. Cox proportional hazards models were used to estimate the risks of stroke/SE and major bleeding of each DOAC vs. warfarin. Two-part models were used to compare the stroke/SE- and major-bleeding-related medical costs between matched cohorts. Results: Of the 186,132 eligible patients, 20,803 apixaban-warfarin pairs, 52,476 rivaroxaban-warfarin pairs, and 16,731 dabigatran-warfarin pairs were matched. Apixaban (hazard ratio [HR]=0.40; 95% confidence interval [CI] 0.31, 0.53) and rivaroxaban (HR=0.72; 95% CI 0.63, 0.83) were significantly associated with lower risk of stroke/SE compared to warfarin. Apixaban (HR=0.51; 95% CI 0.44, 0.58) and dabigatran (HR=0.79; 95% CI 0.69, 0.91) were significantly associated with lower risk of major bleeding; rivaroxaban (HR=1.17; 95% CI 1.10, 1.26) was significantly associated with higher risk of major bleeding compared to warfarin. Compared to warfarin, apixaban ($63 vs. $131) and rivaroxaban ($93 vs. $139) had significantly lower stroke/SE-related medical costs; apixaban ($292 vs. $529) and dabigatran ($369 vs. $450) had significantly lower major bleeding-related medical costs. Conclusions: Among the DOACs in the study, only apixaban is associated with a significantly lower risk of stroke/SE and major bleeding and lower related medical costs compared to warfarin.